Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 232 entries
Sorted by: Best Match Show Resources per page
Photoconductance oscillations in a two-dimensional quantum point contact.

Physical review. B, Condensed matter

Gorelik LY, Grincwajg A, Kleiner VZ, Shekhter RI.
PMID: 9980360
Phys Rev B Condens Matter. 1995 Oct 15;52(16):12168-12178. doi: 10.1103/physrevb.52.12168.

No abstract available.

Cite
Gorelik LY, Grincwajg A, Kleiner VZ, et al. Photoconductance oscillations in a two-dimensional quantum point contact. Phys Rev B Condens Matter. 1995;52(16):12168-12178doi: 10.1103/physrevb.52.12168.
Gorelik, L. Y., Grincwajg, A., Kleiner, V. Z., & Shekhter, R. I. (1995). Photoconductance oscillations in a two-dimensional quantum point contact. Physical review. B, Condensed matter, 52(16), 12168-12178. https://doi.org/10.1103/physrevb.52.12168
Gorelik, et al. "Photoconductance oscillations in a two-dimensional quantum point contact." Physical review. B, Condensed matter vol. 52,16 (1995): 12168-12178. doi: https://doi.org/10.1103/physrevb.52.12168
Gorelik LY, Grincwajg A, Kleiner VZ, Shekhter RI. Photoconductance oscillations in a two-dimensional quantum point contact. Phys Rev B Condens Matter. 1995 Oct 15;52(16):12168-12178. doi: 10.1103/physrevb.52.12168. PMID: 9980360.
Copy Download .nbib Format: NLM
Production of pi 0 mesons at high pT in pi -Be and pBe collisions at 500 GeV/c.

Physical review. D, Particles and fields

Alverson G, Baker WF, Ballocchi G, Benson R, Berg D, Blusk S, Bromberg C, Brown D, Carey D, Chand T, Chandlee C, Choudhary BC, Chung WH, de Barbaro L, DeSoi W, Dlugosz W, Dunlea J, Easo S, Engels E, Faissler W, Fanourakis G, Ferbel T, Garelick D, Ginther G, Glass G, Glaubman M, Gutierrez P, Hartman K, Huston J, Johnstone C, Kapoor V, Kourbanis I, Lanaro A, Lirakis C, Lobkowicz F, Lukens P, Mani S, Mansour J, Maul A, Miller R, Nelson CA, Oh B, Orris D, Pothier E, Prebys E, Rajaram BM, Roser R, Ruddick K, Shepard P, Shivpuri RK, Sinanidis A, Skow D, Slattery P, Sorrell L, Toothacker W, Varelas N, Weerasundara D, Whitmore J, Wu G, Yasuda T, Yosef C, Zielinski M.
PMID: 10014345
Phys Rev D Part Fields. 1992 Jun 01;45(11):R3899-R3902. doi: 10.1103/physrevd.45.r3899.

No abstract available.

Cite
Alverson G, Baker WF, Ballocchi G, et al. Production of pi 0 mesons at high pT in pi -Be and pBe collisions at 500 GeV/c. Phys Rev D Part Fields. 1992;45(11):R3899-R3902doi: 10.1103/physrevd.45.r3899.
Alverson, G., Baker, W. F., Ballocchi, G., Benson, R., Berg, D., Blusk, S., Bromberg, C., Brown, D., Carey, D., Chand, T., Chandlee, C., Choudhary, B. C., Chung, W. H., de Barbaro L, DeSoi, W., Dlugosz, W., Dunlea, J., Easo, S., Engels, E., Faissler, W., Fanourakis, G., Ferbel, T., Garelick, D., Ginther, G., Glass, G., Glaubman, M., Gutierrez, P., Hartman, K., Huston, J., Johnstone, C., Kapoor, V., Kourbanis, I., Lanaro, A., Lirakis, C., Lobkowicz, F., Lukens, P., Mani, S., Mansour, J., Maul, A., Miller, R., Nelson, C. A., Oh, B., Orris, D., Pothier, E., Prebys, E., Rajaram, B. M., Roser, R., Ruddick, K., Shepard, P., Shivpuri, R. K., Sinanidis, A., Skow, D., Slattery, P., Sorrell, L., Toothacker, W., Varelas, N., Weerasundara, D., Whitmore, J., Wu, G., Yasuda, T., Yosef, C., & Zielinski, M. (1992). Production of pi 0 mesons at high pT in pi -Be and pBe collisions at 500 GeV/c. Physical review. D, Particles and fields, 45(11), R3899-R3902. https://doi.org/10.1103/physrevd.45.r3899
Alverson, et al. "Production of pi 0 mesons at high pT in pi -Be and pBe collisions at 500 GeV/c." Physical review. D, Particles and fields vol. 45,11 (1992): R3899-R3902. doi: https://doi.org/10.1103/physrevd.45.r3899
Alverson G, Baker WF, Ballocchi G, Benson R, Berg D, Blusk S, Bromberg C, Brown D, Carey D, Chand T, Chandlee C, Choudhary BC, Chung WH, de Barbaro L, DeSoi W, Dlugosz W, Dunlea J, Easo S, Engels E, Faissler W, Fanourakis G, Ferbel T, Garelick D, Ginther G, Glass G, Glaubman M, Gutierrez P, Hartman K, Huston J, Johnstone C, Kapoor V, Kourbanis I, Lanaro A, Lirakis C, Lobkowicz F, Lukens P, Mani S, Mansour J, Maul A, Miller R, Nelson CA, Oh B, Orris D, Pothier E, Prebys E, Rajaram BM, Roser R, Ruddick K, Shepard P, Shivpuri RK, Sinanidis A, Skow D, Slattery P, Sorrell L, Toothacker W, Varelas N, Weerasundara D, Whitmore J, Wu G, Yasuda T, Yosef C, Zielinski M. Production of pi 0 mesons at high pT in pi -Be and pBe collisions at 500 GeV/c. Phys Rev D Part Fields. 1992 Jun 01;45(11):R3899-R3902. doi: 10.1103/physrevd.45.r3899. PMID: 10014345.
Copy Download .nbib Format: NLM
Production of direct photons and neutral mesons at large transverse momenta by pi - and p beams at 500 GeV/c.

Physical review. D, Particles and fields

Alverson G, Baker WF, Ballocchi G, Benson R, Berg D, Blusk S, Bromberg C, Brown D, Carey D, Chand T, Chandlee C, Choudhary BC, Chung WH, de Barbaro L, DeSoi W, Dlugosz W, Dunlea J, Easo S, Engels E, Faissler W, Fanourakis G, Ferbel T, Garelick D, Ginther G, Glass G, Glaubman M, Gutierrez P, Hartman K, Huston J, Johnstone C, Kapoor V, Kourbanis L, Lanaro A, Lirakis C, Lobkowicz F, Lukens P, Mani S, Mansour J, Maul A, Miller R, Nelson CA, Oh BY, Orris D, Pothier E, Prebys E, Rajaram BM, Roser R, Ruddick K, Shepard P, Shivpuri RK, Sinanidis A, Skow D, Slattery P, Sorrell L, Toothacker W, Varelas N, Weerasundara D, Whitmore J, Wu G, Yasuda T, Yosef C, Zielinski M.
PMID: 10016058
Phys Rev D Part Fields. 1993 Jul 01;48(1):5-28. doi: 10.1103/physrevd.48.5.

No abstract available.

Cite
Alverson G, Baker WF, Ballocchi G, et al. Production of direct photons and neutral mesons at large transverse momenta by pi - and p beams at 500 GeV/c. Phys Rev D Part Fields. 1993;48(1):5-28doi: 10.1103/physrevd.48.5.
Alverson, G., Baker, W. F., Ballocchi, G., Benson, R., Berg, D., Blusk, S., Bromberg, C., Brown, D., Carey, D., Chand, T., Chandlee, C., Choudhary, B. C., Chung, W. H., de Barbaro L, DeSoi, W., Dlugosz, W., Dunlea, J., Easo, S., Engels, E., Faissler, W., Fanourakis, G., Ferbel, T., Garelick, D., Ginther, G., Glass, G., Glaubman, M., Gutierrez, P., Hartman, K., Huston, J., Johnstone, C., Kapoor, V., Kourbanis, L., Lanaro, A., Lirakis, C., Lobkowicz, F., Lukens, P., Mani, S., Mansour, J., Maul, A., Miller, R., Nelson, C. A., Oh, B. Y., Orris, D., Pothier, E., Prebys, E., Rajaram, B. M., Roser, R., Ruddick, K., Shepard, P., Shivpuri, R. K., Sinanidis, A., Skow, D., Slattery, P., Sorrell, L., Toothacker, W., Varelas, N., Weerasundara, D., Whitmore, J., Wu, G., Yasuda, T., Yosef, C., & Zielinski, M. (1993). Production of direct photons and neutral mesons at large transverse momenta by pi - and p beams at 500 GeV/c. Physical review. D, Particles and fields, 48(1), 5-28. https://doi.org/10.1103/physrevd.48.5
Alverson, et al. "Production of direct photons and neutral mesons at large transverse momenta by pi - and p beams at 500 GeV/c." Physical review. D, Particles and fields vol. 48,1 (1993): 5-28. doi: https://doi.org/10.1103/physrevd.48.5
Alverson G, Baker WF, Ballocchi G, Benson R, Berg D, Blusk S, Bromberg C, Brown D, Carey D, Chand T, Chandlee C, Choudhary BC, Chung WH, de Barbaro L, DeSoi W, Dlugosz W, Dunlea J, Easo S, Engels E, Faissler W, Fanourakis G, Ferbel T, Garelick D, Ginther G, Glass G, Glaubman M, Gutierrez P, Hartman K, Huston J, Johnstone C, Kapoor V, Kourbanis L, Lanaro A, Lirakis C, Lobkowicz F, Lukens P, Mani S, Mansour J, Maul A, Miller R, Nelson CA, Oh BY, Orris D, Pothier E, Prebys E, Rajaram BM, Roser R, Ruddick K, Shepard P, Shivpuri RK, Sinanidis A, Skow D, Slattery P, Sorrell L, Toothacker W, Varelas N, Weerasundara D, Whitmore J, Wu G, Yasuda T, Yosef C, Zielinski M. Production of direct photons and neutral mesons at large transverse momenta by pi - and p beams at 500 GeV/c. Phys Rev D Part Fields. 1993 Jul 01;48(1):5-28. doi: 10.1103/physrevd.48.5. PMID: 10016058.
Copy Download .nbib Format: NLM
Symptom burden in malignant and non-malignant disease on admission to a palliative care unit.

BMJ supportive & palliative care

See D, Le B, Gorelik A, Eastman P.
PMID: 30723074
BMJ Support Palliat Care. 2019 Feb 04; doi: 10.1136/bmjspcare-2018-001560. Epub 2019 Feb 04.

BACKGROUND: There is increasing recognition that patients with non-malignant diseases have comparable physical and psychosocial symptom burden to patients with cancer. There is currently limited data directly comparing symptom burden between these patient groups.OBJECTIVE: To investigate differences in symptom...

Cite
See D, Le B, Gorelik A, et al. Symptom burden in malignant and non-malignant disease on admission to a palliative care unit. BMJ Support Palliat Care. 2019;doi: 10.1136/bmjspcare-2018-001560.
See, D., Le, B., Gorelik, A., & Eastman, P. (2019). Symptom burden in malignant and non-malignant disease on admission to a palliative care unit. BMJ supportive & palliative care, . https://doi.org/10.1136/bmjspcare-2018-001560
See, David, et al. "Symptom burden in malignant and non-malignant disease on admission to a palliative care unit." BMJ supportive & palliative care vol. (2019). doi: https://doi.org/10.1136/bmjspcare-2018-001560
See D, Le B, Gorelik A, Eastman P. Symptom burden in malignant and non-malignant disease on admission to a palliative care unit. BMJ Support Palliat Care. 2019 Feb 04; doi: 10.1136/bmjspcare-2018-001560. Epub 2019 Feb 04. PMID: 30723074.
Copy Download .nbib Format: NLM
Fatal and Near-Fatal Non-allergic Reactions in Patients with Underlying Cardiac Disease Receiving Benzathine Penicillin G in Israel and Switzerland.

Frontiers in pharmacology

Berkovitch M, Ashkenazi-Hoffnung L, Youngster I, Shaniv D, Dil-Nahlieli D, Gorelik E, Schäublin M, Stoller R, Karra N, Schwartzberg E.
PMID: 29209214
Front Pharmacol. 2017 Nov 21;8:843. doi: 10.3389/fphar.2017.00843. eCollection 2017.

Benzathine Penicillin G (BPG) is commonly used for treatment of penicillin-susceptible infections and secondary prevention of rheumatic fever. Death following administration of BPG is extremely rare-only a handful of cases have been described in the literature since the 1950's....

Cite
Berkovitch M, Ashkenazi-Hoffnung L, Youngster I, et al. Fatal and Near-Fatal Non-allergic Reactions in Patients with Underlying Cardiac Disease Receiving Benzathine Penicillin G in Israel and Switzerland. Front Pharmacol. 2017;8:843doi: 10.3389/fphar.2017.00843.
Berkovitch, M., Ashkenazi-Hoffnung, L., Youngster, I., Shaniv, D., Dil-Nahlieli, D., Gorelik, E., Schäublin, M., Stoller, R., Karra, N., & Schwartzberg, E. (2017). Fatal and Near-Fatal Non-allergic Reactions in Patients with Underlying Cardiac Disease Receiving Benzathine Penicillin G in Israel and Switzerland. Frontiers in pharmacology, 8843. https://doi.org/10.3389/fphar.2017.00843
Berkovitch, Matitiahu, et al. "Fatal and Near-Fatal Non-allergic Reactions in Patients with Underlying Cardiac Disease Receiving Benzathine Penicillin G in Israel and Switzerland." Frontiers in pharmacology vol. 8 (2017): 843. doi: https://doi.org/10.3389/fphar.2017.00843
Berkovitch M, Ashkenazi-Hoffnung L, Youngster I, Shaniv D, Dil-Nahlieli D, Gorelik E, Schäublin M, Stoller R, Karra N, Schwartzberg E. Fatal and Near-Fatal Non-allergic Reactions in Patients with Underlying Cardiac Disease Receiving Benzathine Penicillin G in Israel and Switzerland. Front Pharmacol. 2017 Nov 21;8:843. doi: 10.3389/fphar.2017.00843. eCollection 2017. PMID: 29209214; PMCID: PMC5702457.
Copy Download .nbib Format: NLM
Adaptation of neurological practice and policy to a changing US health-care landscape.

The Lancet. Neurology

Gorelick PB.
PMID: 26971663
Lancet Neurol. 2016 Apr;15(4):444-50. doi: 10.1016/S1474-4422(16)00020-X.

Health care in the USA is undergoing a drastic transformation under the Patient Protection and Affordable Care Act. The Patient Protection and Affordable Care Act is driving major health-care policy changes by connecting payment for traditional health-care services to...

Cite
Gorelick PB. Adaptation of neurological practice and policy to a changing US health-care landscape. Lancet Neurol. 2016;15(4):444-50doi: 10.1016/S1474-4422(16)00020-X.
Gorelick, P. B. (2016). Adaptation of neurological practice and policy to a changing US health-care landscape. The Lancet. Neurology, 15(4), 444-50. https://doi.org/10.1016/S1474-4422(16)00020-X
Gorelick, Philip B. "Adaptation of neurological practice and policy to a changing US health-care landscape." The Lancet. Neurology vol. 15,4 (2016): 444-50. doi: https://doi.org/10.1016/S1474-4422(16)00020-X
Gorelick PB. Adaptation of neurological practice and policy to a changing US health-care landscape. Lancet Neurol. 2016 Apr;15(4):444-50. doi: 10.1016/S1474-4422(16)00020-X. PMID: 26971663.
Copy Download .nbib Format: NLM
Erratum to: Determinants of bone mineral density in young Australian women; results from the Safe-D study.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Callegari ET, Garland SM, Gorelik A, Wark JD.
PMID: 28879378
Osteoporos Int. 2017 Nov;28(11):3287-3288. doi: 10.1007/s00198-017-4210-1.

No abstract available.

Cite
Callegari ET, Garland SM, Gorelik A, et al. Erratum to: Determinants of bone mineral density in young Australian women; results from the Safe-D study. Osteoporos Int. 2017;28(11):3287-3288doi: 10.1007/s00198-017-4210-1.
Callegari, E. T., Garland, S. M., Gorelik, A., & Wark, J. D. (2017). Erratum to: Determinants of bone mineral density in young Australian women; results from the Safe-D study. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 28(11), 3287-3288. https://doi.org/10.1007/s00198-017-4210-1
Callegari, E T, et al. "Erratum to: Determinants of bone mineral density in young Australian women; results from the Safe-D study." Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA vol. 28,11 (2017): 3287-3288. doi: https://doi.org/10.1007/s00198-017-4210-1
Callegari ET, Garland SM, Gorelik A, Wark JD. Erratum to: Determinants of bone mineral density in young Australian women; results from the Safe-D study. Osteoporos Int. 2017 Nov;28(11):3287-3288. doi: 10.1007/s00198-017-4210-1. PMID: 28879378.
Copy Download .nbib Format: NLM
Outlining where humans live, the World Settlement Footprint 2015.

Scientific data

Marconcini M, Metz-Marconcini A, Üreyen S, Palacios-Lopez D, Hanke W, Bachofer F, Zeidler J, Esch T, Gorelick N, Kakarla A, Paganini M, Strano E.
PMID: 32686674
Sci Data. 2020 Jul 20;7(1):242. doi: 10.1038/s41597-020-00580-5.

Human settlements are the cause and consequence of most environmental and societal changes on Earth; however, their location and extent is still under debate. We provide here a new 10 m resolution (0.32 arc sec) global map of human...

Cite
Marconcini M, Metz-Marconcini A, Üreyen S, et al. Outlining where humans live, the World Settlement Footprint 2015. Sci Data. 2020;7(1):242doi: 10.1038/s41597-020-00580-5.
Marconcini, M., Metz-Marconcini, A., Üreyen, S., Palacios-Lopez, D., Hanke, W., Bachofer, F., Zeidler, J., Esch, T., Gorelick, N., Kakarla, A., Paganini, M., & Strano, E. (2020). Outlining where humans live, the World Settlement Footprint 2015. Scientific data, 7(1), 242. https://doi.org/10.1038/s41597-020-00580-5
Marconcini, Mattia, et al. "Outlining where humans live, the World Settlement Footprint 2015." Scientific data vol. 7,1 (2020): 242. doi: https://doi.org/10.1038/s41597-020-00580-5
Marconcini M, Metz-Marconcini A, Üreyen S, Palacios-Lopez D, Hanke W, Bachofer F, Zeidler J, Esch T, Gorelick N, Kakarla A, Paganini M, Strano E. Outlining where humans live, the World Settlement Footprint 2015. Sci Data. 2020 Jul 20;7(1):242. doi: 10.1038/s41597-020-00580-5. PMID: 32686674; PMCID: PMC7371630.
Copy Download .nbib Format: NLM
Ecdysteroid Content and Therapeutic Activity in Elicited Spinach Accessions.

Plants (Basel, Switzerland)

Gorelick J, Iraqi RH, Bernstein N.
PMID: 32526841
Plants (Basel). 2020 Jun 09;9(6). doi: 10.3390/plants9060727.

While spinach is an established nutritionally important crop, its medicinal value is not as well known. Spinach is rich in ecdysteroids, insect hormone analogs with a number of medicinal properties including anti-oxidative, anti-inflammatory and even anabolic activity. However, the...

Cite
Gorelick J, Iraqi RH, Bernstein N. Ecdysteroid Content and Therapeutic Activity in Elicited Spinach Accessions. Plants (Basel). 2020;9(6)doi: 10.3390/plants9060727.
Gorelick, J., Iraqi, R. H., & Bernstein, N. (2020). Ecdysteroid Content and Therapeutic Activity in Elicited Spinach Accessions. Plants (Basel, Switzerland), 9(6), . https://doi.org/10.3390/plants9060727
Gorelick, Jonathan, et al. "Ecdysteroid Content and Therapeutic Activity in Elicited Spinach Accessions." Plants (Basel, Switzerland) vol. 9,6 (2020). doi: https://doi.org/10.3390/plants9060727
Gorelick J, Iraqi RH, Bernstein N. Ecdysteroid Content and Therapeutic Activity in Elicited Spinach Accessions. Plants (Basel). 2020 Jun 09;9(6). doi: 10.3390/plants9060727. PMID: 32526841; PMCID: PMC7356866.
Copy Download .nbib Format: NLM
Leveraging Systematic Functional Analysis to Benchmark an .

Cancer research

Hanrahan AJ, Sylvester BE, Chang MT, Elzein A, Gao J, Han W, Liu Y, Xu D, Gao SP, Gorelick AN, Jones AM, Kiliti AJ, Nissan MH, Nimura CA, Poteshman AN, Yao Z, Gao Y, Hu W, Wise HC, Gavrila EI, Shoushtari AN, Tiwari S, Viale A, Abdel-Wahab O, Merghoub T, Berger MF, Rosen N, Taylor BS, Solit DB.
PMID: 32641410
Cancer Res. 2020 Oct 01;80(19):4233-4243. doi: 10.1158/0008-5472.CAN-20-0865. Epub 2020 Jul 08.

Despite significant advances in cancer precision medicine, a significant hurdle to its broader adoption remains the multitude of variants of unknown significance identified by clinical tumor sequencing and the lack of biologically validated methods to distinguish between functional and...

Cite
Hanrahan AJ, Sylvester BE, Chang MT, et al. Leveraging Systematic Functional Analysis to Benchmark an . Cancer Res. 2020;80(19):4233-4243doi: 10.1158/0008-5472.CAN-20-0865.
Hanrahan, A. J., Sylvester, B. E., Chang, M. T., Elzein, A., Gao, J., Han, W., Liu, Y., Xu, D., Gao, S. P., Gorelick, A. N., Jones, A. M., Kiliti, A. J., Nissan, M. H., Nimura, C. A., Poteshman, A. N., Yao, Z., Gao, Y., Hu, W., Wise, H. C., Gavrila, E. I., Shoushtari, A. N., Tiwari, S., Viale, A., Abdel-Wahab, O., Merghoub, T., Berger, M. F., Rosen, N., Taylor, B. S., & Solit, D. B. (2020). Leveraging Systematic Functional Analysis to Benchmark an . Cancer research, 80(19), 4233-4243. https://doi.org/10.1158/0008-5472.CAN-20-0865
Hanrahan, Aphrothiti J, et al. "Leveraging Systematic Functional Analysis to Benchmark an ." Cancer research vol. 80,19 (2020): 4233-4243. doi: https://doi.org/10.1158/0008-5472.CAN-20-0865
Hanrahan AJ, Sylvester BE, Chang MT, Elzein A, Gao J, Han W, Liu Y, Xu D, Gao SP, Gorelick AN, Jones AM, Kiliti AJ, Nissan MH, Nimura CA, Poteshman AN, Yao Z, Gao Y, Hu W, Wise HC, Gavrila EI, Shoushtari AN, Tiwari S, Viale A, Abdel-Wahab O, Merghoub T, Berger MF, Rosen N, Taylor BS, Solit DB. Leveraging Systematic Functional Analysis to Benchmark an . Cancer Res. 2020 Oct 01;80(19):4233-4243. doi: 10.1158/0008-5472.CAN-20-0865. Epub 2020 Jul 08. PMID: 32641410; PMCID: PMC7541597.
Copy Download .nbib Format: NLM
Understanding Treatment Preferences in Patients with Moderate to Severe Plaque Psoriasis in the USA: Results from a Cross-Sectional Patient Survey.

Dermatology and therapy

Gorelick J, Shrom D, Sikand K, Renda L, Burge R, Dworkin C, Krebsbach C, Patel RP, Karki C, Rosmarin D.
PMID: 31630336
Dermatol Ther (Heidelb). 2019 Dec;9(4):785-797. doi: 10.1007/s13555-019-00334-1. Epub 2019 Oct 19.

INTRODUCTION: The goal of psoriasis (PsO) treatment is to improve quality of life by lessening the extent and severity of the disease. Traditional systemic drugs and biologic agents are used for the treatment of moderate to severe PsO and...

Cite
Gorelick J, Shrom D, Sikand K, et al. Understanding Treatment Preferences in Patients with Moderate to Severe Plaque Psoriasis in the USA: Results from a Cross-Sectional Patient Survey. Dermatol Ther (Heidelb). 2019;9(4):785-797doi: 10.1007/s13555-019-00334-1.
Gorelick, J., Shrom, D., Sikand, K., Renda, L., Burge, R., Dworkin, C., Krebsbach, C., Patel, R. P., Karki, C., & Rosmarin, D. (2019). Understanding Treatment Preferences in Patients with Moderate to Severe Plaque Psoriasis in the USA: Results from a Cross-Sectional Patient Survey. Dermatology and therapy, 9(4), 785-797. https://doi.org/10.1007/s13555-019-00334-1
Gorelick, Joe, et al. "Understanding Treatment Preferences in Patients with Moderate to Severe Plaque Psoriasis in the USA: Results from a Cross-Sectional Patient Survey." Dermatology and therapy vol. 9,4 (2019): 785-797. doi: https://doi.org/10.1007/s13555-019-00334-1
Gorelick J, Shrom D, Sikand K, Renda L, Burge R, Dworkin C, Krebsbach C, Patel RP, Karki C, Rosmarin D. Understanding Treatment Preferences in Patients with Moderate to Severe Plaque Psoriasis in the USA: Results from a Cross-Sectional Patient Survey. Dermatol Ther (Heidelb). 2019 Dec;9(4):785-797. doi: 10.1007/s13555-019-00334-1. Epub 2019 Oct 19. PMID: 31630336; PMCID: PMC6828866.
Copy Download .nbib Format: NLM
Decreased plasma levels of the survival factor renalase are associated with worse outcomes in COVID-19.

medRxiv : the preprint server for health sciences

Wang M, Guo X, Chun HJ, Lee AI, Cha C, Gorelick F, Desir GV.
PMID: 32577678
medRxiv. 2020 Jun 09; doi: 10.1101/2020.06.02.20120865.

INTRODUCTION: Renalase (RNLS), a novel secreted plasma flavoprotein, has anti-inflammatory effects in a variety of disease processes. Severe COVID-19 disease is associated with disordered inflammatory responses. We hypothesized that reduced plasma RNLS levels could be a marker of COVID-19...

Cite
Wang M, Guo X, Chun HJ, et al. Decreased plasma levels of the survival factor renalase are associated with worse outcomes in COVID-19. medRxiv. 2020;doi: 10.1101/2020.06.02.20120865.
Wang, M., Guo, X., Chun, H. J., Lee, A. I., Cha, C., Gorelick, F., & Desir, G. V. (2020). Decreased plasma levels of the survival factor renalase are associated with worse outcomes in COVID-19. medRxiv : the preprint server for health sciences, . https://doi.org/10.1101/2020.06.02.20120865
Wang, Melinda, et al. "Decreased plasma levels of the survival factor renalase are associated with worse outcomes in COVID-19." medRxiv : the preprint server for health sciences vol. (2020). doi: https://doi.org/10.1101/2020.06.02.20120865
Wang M, Guo X, Chun HJ, Lee AI, Cha C, Gorelick F, Desir GV. Decreased plasma levels of the survival factor renalase are associated with worse outcomes in COVID-19. medRxiv. 2020 Jun 09; doi: 10.1101/2020.06.02.20120865. PMID: 32577678; PMCID: PMC7302283.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 232 entries